We conducted a prospective interventional study to evaluate the role of endoscopic endonasal dacryocystorhinostomy in children. Our study population was made up of 20 patients-18 boys and 2 girls, aged 2 to 12 years (mean: 5.3)-who presented with signs and symptoms suggestive of nasolacrimal duct blockage that was refractory to conventional medical treatment. In all cases, blockage was confirmed by nasolacrimal duct syringing that demonstrated regurgitation from the opposite punctum. The primary outcome measures for success were resolution of symptoms and duct patency on lacrimal irrigation. At 6 months, 17 patients (85%) experienced complete symptomatic relief, 1 (5%) had partial relief, and 2 (10%) reported no relief. Moreover, the nasolacrimal duct was patent in 17 patients, partially patent in 2, and blocked in 1. We conclude that endoscopic endonasal dacryocystorhinostomy is a safe and effective procedure in children with nasolacrimal duct blockage when medical therapy and probing have been unsuccessful.
Introduction
Epiphora secondary to nasolacrimal duct obstruction in children is usually treated successfully with conservative medical therapy, massage, antibiotics, probing and, if necessary, silicone intubation. 1 For the few children who are refractory to such treat-ment measures because they have a more proximal nasolacrimal system obstruction, surgical intervention in the form of dacryocystorhinostomy is indicated. 2 Pediatric endonasal dacryocystorhinostomy has some particularities inherent to this group of patients. In children, the nasal airways are narrower than they are in adults, and the inferior turbinate is bulkier. Moreover, the nasal septum can be deviated (a septoplasty is not recommended for children because of its possible impact on facial growth). In addition, the agger nasi cells in children are not as well pneumatized as they are in adults, and identification of the lacrimal eminence and the uncinate process can be more difficult in such a narrow space. 1 All of these factors can make endonasal dacryocystorhinostomy more difficult.
Only a few studies and series of endonasal dacryocystorhinostomy in children have been published, and their findings generally have been favorable. 1, [3] [4] [5] [6] [7] [8] [9] [10] Encouraged by these results and motivated by the dearth of literature on pediatric dacryocystorhinostomy in Asian Indians, we conducted our own study.
Patients and methods
This prospective study was conducted in our Department of Otorhinolaryngology in collaboration with the Department of Ophthalmology. Our study population was made up of 20 patients-18 boys and 2 girls, aged 2 to 12 years (mean: 5.3 ± 2.59)-who presented with signs and symptoms suggestive of nasolacrimal duct blockage refractory to conventional medical treatment (table 1) . Our exclusion criteria included a history of previous dacryocystorhinostomy, a marked deviation of the nasal septum to the same side, and the presence of nasal polyps, bleeding disorder, or a nasal tumor.
Presenting symptoms. The most common presenting symptoms were watery eyes (n = 20) and other eye discharge (n = 16); in addition, 1 patient exhibited swelling over the lower eyelid caused by a mucocele. The onset of their symptoms ranged from 1 to 8 years.
Diagnosis. In all cases, blockage was confirmed by nasolacrimal duct syringing that demonstrated regurgitation from the opposite punctum.
Causes of obstruction. Nasolacrimal duct obstruction was acquired in 12 of the 20 patients and congenital in the other 8. Among the former, the cause was unknown in 11 and the result of trauma in 1. The congenital cases were isolated in 7 patients and associated with other anomalies (i.e., syndactyly and telecanthus) in 1 (table 2). Surgical technique. Most patients underwent surgery within 4 years after the onset of symptoms. Before surgery, they had been treated conservatively.
In the operating room, all patients were administered general anesthesia. The area of the lateral nasal wall was infiltrated with saline with 1:100,000 epinephrine (adrenalin). Both 0°and 30° endoscopes were used during surgery.
A horizontal incision was made with a sickle knife just above the anterior attachment of the middle turbinate, and another horizontal incision was made anterior to the root of the inferior turbinate. A vertical incision joined the two horizontal incisions over the frontal process of the maxilla. A mucoperiosteal flap was raised with a Freer elevator, and the flap was removed with a through-cutting forceps. The frontal process of the maxilla was identified, and it was removed with a Kerrison punch. Thin lacrimal bone was removed with a through-cutting forceps.
The bony window was enlarged to a diameter of approximately 8 to 10 mm. The medial wall of the lacrimal sac was tented with a lacrimal probe by an eye surgeon. The incision was made over the medial wall of the sac with a sickle knife. A ball probe was used when required to break adhesions between the medial and lateral walls. The medial wall of the sac was removed with a through-cutting forceps.
Lacrimal syringing was performed with normal saline to confirm the patency of the duct. A stent was placed through the upper and lower punctum and into the nose through the ostium made in the lateral wall of the nasal cavity; the stent was then tied in the nose. The nasal cavity was packed with roll gauze immersed in framycetin ointment.
Postoperative care. The packing material was removed the day after surgery, and patients were discharged on an oral antibiotic, antihistamine, analgesic, saline nasal drops, and antibiotic eye drops for 7 days. The stent was removed after 6 weeks.
Outcomes measures. Patients were followed up at 1 week, 6 weeks (when the stent was removed), and 6 months, at which time the final results were recorded.
The results of surgery were graded subjectively as complete relief of symptoms, partial relief, or no relief. Objective results were based on the patency of the duct as determined by syringing; the status of the duct was classified as patent (no resistance to the flow of the saline), partially patent (some saline regurgitated), and blocked (no flow).
Results
Operative findings. During dacryocystorhinostomy, 10 of the 20 patients exhibited a mucoid discharge on incision of the medial wall of the lacrimal sac, 4 patients expressed a watery discharge, 3 patients a mucopurulent discharge, and 3 patients a purulent discharge.
Outcomes. On subjective assessments at 6 months, 17 patients (85%) experienced complete relief, 1 patient (5%) partial relief, and 2 patients (10%) no relief (table  3) . Among the 17 patients with complete relief, 1 patient experienced sudden expulsion of the stent.
Objectively, nasolacrimal duct syringing at 6 months revealed 17 patent ducts, 2 partially patent ducts, and 1 blocked duct (table 3) . Complications. No major complication occurred in our study. Minor intraoperative bleeding was observed in 2 patients and, as mentioned, a spontaneous postoperative expulsion of the lacrimal stent was observed in 1 patient.
Discussion
Acquired obstruction of the nasolacrimal ducts is usually idiopathic, and it requires surgical intervention. 1 In our study, 12 patients had acquired obstruction, the cause of which was unknown in 11.
Congenital obstruction of the nasolacrimal passages frequently responds to conservative management with manual compression over the lacrimal sac and a topical antibiotic. Patients who are refractory to conservative treatment can be managed by probing, provided they are older than 4 months. If this fails, they can then be treated with dacryocystorhinostomy. Eight patients in our study had a congenital obstruction. Of these, 7 were isolated, while the other was associated with syndactyly and telecanthus.
Eloy et al studied 8 patients with congenital nasolacrimal duct obstruction, 3 of whom had a craniofacial anomaly. 1 Komínek and Cervenka studied 34 patients and reported a history of facial trauma in 4 of them. 6 Jones et al found 7 cases of craniofacial abnormalities in their study of patients with congenital obstruction. 8 On the other hand, Leibovitch et al found no associated anomalies among 21 children with congenital obstruction. 9 In the ophthalmology literature, external dacryocystorhinostomy is considered the gold standard for treatment of nasolacrimal duct stenosis. Rhinologists, on other hand, favor the endonasal approach. Conventional dacryocystorhinostomy was first described by Toti in 1904. 11 Since then, it has remained the mainstay of treatment for acquired chronic dacryocystitis.
The relatively high success rate of dacryocystorhinostomy notwithstanding, it has been associated with several complications. They include cutaneous scar formation, potential injury to medial canthal structures, incision-site tissue necrosis, suture abscess, orbital hemorrhage, and immediate and delayed postoperative morbidity. 12 Endonasal dacryocystorhinostomy was first described by West in 1910. 13 However, the technique remained unpopular because of its complexity. However, with the introduction of nasal endoscopes, the transnasal endoscopic approach gained popularity in view of its various advantages over the conventional technique. These advantages include a lack of external scar formation, the fact that it can also correct associated nasal pathology as part of a one-stage procedure, no risk of injury to the medial canthus, preservation of the lacrimal pump mechanism of the orbicularis oculi muscle, less operating time, minimal bleeding, shorter hospital stays, minimal postoperative morbidity, and superiority to the external approach in revision surgery. 14 While many studies of endoscopic dacryocystorhinostomy in adults are available in the literature, only a few reports of endonasal dacryocystorhinostomy in children have been published, with reported success rates of 82 to 88%. 1, [3] [4] [5] [6] [7] [8] [9] [10] Intraoperatively, pediatric dacryocystorhinostomy can be bloodier than the procedure in adults, particularly at the beginning of the procedure when the nasal mucosa is resected. Also, suction is less effective in children. On the other hand, decongestion of the nasal mucosa is less important in children than in adults. Topical epinephrine only is used in very young children, as infiltration with lidocaine plus epinephrine is contraindicated in this age group. The dosage of epinephrine must be based on the child's weight to avoid overdosing. 1 In our study, patients ranged in age from 2 to 12 years (mean: 5.3), and most were aged 2 to 5 years. Cunningham and Woog performed endonasal dacryocystorhinostomy in 4 children whose ages ranged from 10 months to 6 years. 3 Berlucchi et al 4 and Knijnik 5 studied children aged 2 to 12 years, with a mean age of 6 and 5.7 years, respectively. Komínek and Cervenka performed endonasal dacryocystorhinostomy in children aged 4 months to 14 years (mean: 4.5 yr). 6 Eloy et al 1 performed the procedure in patients aged 8 months to 9 years (mean: 4.3 yr), and Gupta and Bansal 7 did likewise in children aged 4 to 7 years.
All patients in our study exhibited epiphora. It was associated with discharge (mucoid or mucopurulent) in 80% of our patients and with mucocele in 5%. Gupta and Bansal also reported epiphora in 100% of cases, as well as discharge in 77% and mucocele in 61%. 7 Eloy et al reported epiphora in 100% of cases, discharge in 81%, and dacryocystitis in 18%. 1 Epiphora is common in newborns; an incidence as high as 20% has been reported. 15 Fortunately, more than 95% will undergo spontaneous resolution during their first 12 months of life; of the remaining cases, 60% will resolve within the next 12 months. 15 In addition to watery eyes, reflux conjunctivitis is occasionally seen. Usually these symptoms manifest at about 10 to 30 days after birth.
The most common cause of the epiphora is atresia of the distal end of the nasolacrimal duct, which causes the lacrimal sac to fill and distend with tears and secretions from the goblet cells and other secretory glands of the sac wall. When the content of the sac becomes infected and purulent, it eventually causes dacryocystitis. 16 Obstruction at two sites (proximally at the punctum or the valve of Rosenmüller or distally at the valve of Hasner) can lead to stasis of secretions and formation of a mucocele or a pyocele that presents as a medial canthal mass.
The purpose of nasolacrimal stenting is to maintain ostium patency during the expected period of wound contracture. In our study, stents were removed at 6 weeks postoperatively. Knijnik 5 also maintained stents for 6 weeks, while Leibovitch et al 9 kept their stents in for 5 weeks. Berlucchi et al 4 kept stents in place for 6 months, and Komínek and Cervenka 6 removed stents at 4 to 8 months.
Regardless of whether dacryocystorhinostomy is performed externally or endonasally, some children experience problems related to stents. The intraoperative application of a topical agent such as mitomycin C and the postoperative administration of an intranasal steroid spray may help decrease the risk of granulation tissue formation on the silicone stents. 10 Our findings with endonasal dacryocystorhinostomy were assessed subjectively by self-evaluations of symptom relief and objectively by nasolacrimal duct syringing. Complete relief of symptoms at 6 months was seen in 17 patients (85%), while 1 patient had only a partial relief (5%) and 2 patients (10%) experienced no relief. The nasolacrimal passages were found to be patent on syringing in 17 patients (including 1 patient who experienced a spontaneous expulsion of the stent), partially patent in 2 patients, and blocked in 1.
Knijnik 5 1 In terms of external dacryocystorhinostomy, Maheshwari 17 reported a success rate of 97.5%, and Barnes et al 18 a success rate of 96%. These findings show that external dacryocystorhinostomy is no more effective than the endonasal technique. However, as mentioned, the endonasal technique has advantages in terms of avoiding facial scarring, shortening hospital stays, lowering the incidence of complications, preserving the pump mechanism of tearing, and allowing for the simultaneous treatment of other sinonasal disorders. 4 The effectiveness of endonasal dacryocystorhinostomy also extends to its use in adults, as a success rate of 98.6% was reported by Vishwakarma et al, 19 96% by Sprekelsen and Barberán, 20 and 88% by Sham and van Hasselt. 21 We observed no major intra-or postoperative complications in our study. Minor intraoperative bleeding occurred in 2 patients (10%), and spontaneous stent extrusion occurred in 1 (5%). Gupta and Bansal also reported intraoperative bleeding, which was profuse in 1 patient and required a temporary tamponade before surgery could be completed; in addition, 2 patients experienced minimal orbital emphysema, which subsided within 24 hours with local treatment. 7 Spontaneous stent extrusion was also reported by Knijnik. 5 Cunningham and Woog reported abrasion of the nasal vestibule secondary to drill-shaft rotation with the potential subsequent development of a hypertrophied scar. 3 Since then, this problem has been resolved by the use of powered instrumentation in which the shaft does not rotate for lacrimal bone removal. 10 In our study, lacrimal bone was removed with a Kerrison bone punch.
We conclude that endoscopic dacryocystorhinostomy is a safe and effective procedure in children when medical therapy and probing have been unsuccessful. Among its advantages are that it obviates the risk of facial scarring, it shortens hospital stays, and it is associated with no major complications.
